Roche, Gilead Reach Tamiflu Agreement

Law360, New York (November 16, 2005, 12:00 AM EST) -- As public health officials nervously prepared for a possible flu pandemic after China revealed it had identified three cases of bird flu in humans, Roche and fellow drug maker Gilead reached an agreement over royalties for the bird flu treatment Tamiflu.

The two companies have agreed to amend a 1996 licensing agreement in which Gilead, the inventor of the drug, licensed the manufacturing and distribution of the drug to Roche.

In the updated agreement, Roche will pay Gilead $62.5 million to cover royalties for 2004 and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.